[Comparison of Mosesᵀᴹ Mode and Conventional Laser in Transurethral Lithotripsy for Kidney Stones].

Kasumi Kanai, Hiromasa Sakamoto, Masafumi Tsuruta, Hirohisa Yano, Teruyoshi Aoyama
{"title":"[Comparison of Mosesᵀᴹ Mode and Conventional Laser in Transurethral Lithotripsy for Kidney Stones].","authors":"Kasumi Kanai, Hiromasa Sakamoto, Masafumi Tsuruta, Hirohisa Yano, Teruyoshi Aoyama","doi":"10.14989/ActaUrolJap_70_10_317","DOIUrl":null,"url":null,"abstract":"<p><p>Transurethral lithotripsy (TUL) using holmium YAG laser has become the standard treatment for kidney stones. Mosesᵀᴹ technology, which delivers the laser with less energy loss, has been introduced and is reported to have advantages over regular laser in terms of shorter operation time and lithotripsy efficiency, but there are few reports from general hospitals. We retrospectively compared the perioperative and postoperative outcome, and complications of 28 cases of TUL using Mosesᵀᴹ mode performed from August 2021 to January 2023 at our hospital, and 25 cases of TUL using regular laser from August 2020 to July 2021. The median stone size was 11.9 and 10.9 mm, the median operation time was 103 and 105 minutes, and the 3-month stone-free rate was 88. 0 and 95.8% for Mosesᵀᴹ mode and regular laser, respectively. No significant difference was observed in the operation time. There was no difference in stone-free rate or complications either. The Mosesᵀᴹ mode group had significantly more cases of ureteral stent removal on the day after placement. In evaluating stone retropulsion on a 4-point scale, Mosesᵀᴹ mode cases showed significantly less retropulsion. TUL using Mosesᵀᴹ mode could be a useful option for treatment of kidney stones.</p>","PeriodicalId":39291,"journal":{"name":"Acta Urologica Japonica","volume":"70 10","pages":"317-321"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Urologica Japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14989/ActaUrolJap_70_10_317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Transurethral lithotripsy (TUL) using holmium YAG laser has become the standard treatment for kidney stones. Mosesᵀᴹ technology, which delivers the laser with less energy loss, has been introduced and is reported to have advantages over regular laser in terms of shorter operation time and lithotripsy efficiency, but there are few reports from general hospitals. We retrospectively compared the perioperative and postoperative outcome, and complications of 28 cases of TUL using Mosesᵀᴹ mode performed from August 2021 to January 2023 at our hospital, and 25 cases of TUL using regular laser from August 2020 to July 2021. The median stone size was 11.9 and 10.9 mm, the median operation time was 103 and 105 minutes, and the 3-month stone-free rate was 88. 0 and 95.8% for Mosesᵀᴹ mode and regular laser, respectively. No significant difference was observed in the operation time. There was no difference in stone-free rate or complications either. The Mosesᵀᴹ mode group had significantly more cases of ureteral stent removal on the day after placement. In evaluating stone retropulsion on a 4-point scale, Mosesᵀᴹ mode cases showed significantly less retropulsion. TUL using Mosesᵀᴹ mode could be a useful option for treatment of kidney stones.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Moses -模式与常规激光在经尿道肾结石碎石中的比较]。
钬激光经尿道碎石术(TUL)已成为肾结石的标准治疗方法。Moses -技术提供的激光能量损失更少,已经被引入,据报道在更短的手术时间和碎石效率方面比常规激光有优势,但来自综合医院的报道很少。回顾性比较我院2021年8月至2023年1月28例使用Moses -模式行TUL的患者,以及2020年8月至2021年7月25例使用常规激光行TUL的患者的围术期、术后预后及并发症。中位结石大小分别为11.9和10.9 mm,中位手术时间分别为103和105分钟,3个月结石清除率为88。Moses - 模态和常规激光分别为0%和95.8%。手术时间差异无统计学意义。两组无结石率及并发症均无差异。在放置输尿管支架后的第一天,Moses组的输尿管支架取出率明显高于对照组。在以4分制评估石头的反推力时,Moses - zi模式的案例显示出明显较少的反推力。使用Moses - 模式的TUL可能是治疗肾结石的有用选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Urologica Japonica
Acta Urologica Japonica Medicine-Medicine (all)
CiteScore
0.20
自引率
0.00%
发文量
74
期刊最新文献
[The Case of Solitary Adrenal Metastasis of Urothelial Carcinoma]. [The Introduction of Pubic Hair into the Bladder : A Possibility of an Alternate Mechanism]. [A Case of Metastatic Testicular Cancer after Kidney Transplantation in which Complete Remission was Achieved]. [A Case of Pelvic Arteriovenous Malformation in a Male with Massive Bladder Bleeding which Caused Severe Hemorrhagic Hypovolemic Shock]. [Risk Factor of Cutaneous Symptoms Associated with Enfortumab Vedotin for Urothelial Carcinoma].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1